Jim Cramer Blesses Rigel Pharmaceuticals as a Spec as “It’s Doing Better Than People Realize”

What: Jim Cramer has endorsed Rigel Pharmaceuticals as a speculative investment.
Why: Cramer believes Rigel is performing better than the market perceives.
Signal: Rigel Pharmaceuticals' stock has increased by **+15%** in the past week.
Target: Cramer's target price for Rigel Pharmaceuticals is set at **$25**.
Risk: Investors should be aware of the high volatility associated with speculative investments like Rigel Pharmaceuticals.